IRIS UniCatt

Locatelli, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 33.229
NA - Nord America 13.880
EU - Europa 7.982
SA - Sud America 6.624
AF - Africa 734
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 62.486
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 16.290
US - Stati Uniti d'America 13.178
CN - Cina 7.886
BR - Brasile 5.505
VN - Vietnam 2.004
IT - Italia 1.602
FR - Francia 1.353
ID - Indonesia 1.320
IE - Irlanda 1.211
KR - Corea 1.011
IN - India 943
DE - Germania 917
JP - Giappone 877
RU - Federazione Russa 782
HK - Hong Kong 735
GB - Regno Unito 514
AR - Argentina 453
BD - Bangladesh 433
IQ - Iraq 370
SE - Svezia 363
MX - Messico 292
FI - Finlandia 249
ZA - Sudafrica 214
CA - Canada 213
TR - Turchia 170
PK - Pakistan 157
AT - Austria 155
NL - Olanda 154
VE - Venezuela 152
EC - Ecuador 145
UA - Ucraina 141
SA - Arabia Saudita 129
PL - Polonia 128
MA - Marocco 114
UZ - Uzbekistan 100
CO - Colombia 99
ES - Italia 97
CZ - Repubblica Ceca 90
JO - Giordania 88
PH - Filippine 86
KE - Kenya 77
PY - Paraguay 72
CL - Cile 70
NP - Nepal 68
EG - Egitto 60
MY - Malesia 59
TH - Thailandia 59
AZ - Azerbaigian 53
AE - Emirati Arabi Uniti 51
DZ - Algeria 50
PE - Perù 47
UY - Uruguay 46
TN - Tunisia 44
ET - Etiopia 42
KZ - Kazakistan 42
IL - Israele 40
JM - Giamaica 40
OM - Oman 40
LB - Libano 34
CR - Costa Rica 32
IR - Iran 30
BO - Bolivia 29
DO - Repubblica Dominicana 26
SN - Senegal 25
CH - Svizzera 24
BH - Bahrain 23
NG - Nigeria 22
PT - Portogallo 22
BG - Bulgaria 21
PA - Panama 21
SY - Repubblica araba siriana 21
AU - Australia 20
HN - Honduras 20
AL - Albania 17
BY - Bielorussia 17
LT - Lituania 17
CI - Costa d'Avorio 16
PS - Palestinian Territory 16
BB - Barbados 15
GE - Georgia 15
TT - Trinidad e Tobago 15
BE - Belgio 14
KG - Kirghizistan 13
RO - Romania 13
RS - Serbia 13
LV - Lettonia 10
CG - Congo 9
KW - Kuwait 9
MD - Moldavia 9
NI - Nicaragua 9
AM - Armenia 8
AO - Angola 8
GA - Gabon 8
HU - Ungheria 8
MM - Myanmar 8
GR - Grecia 7
QA - Qatar 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
BN - Brunei Darussalam 6
Totale 62.351
Salva come PNG Salva come JPEG
Città #
Singapore 7.900
San Jose 3.123
Hefei 2.974
Ashburn 2.836
Jakarta 1.281
Dublin 1.207
Lauterbourg 1.045
Seoul 993
Kent 876
Tokyo 857
Ho Chi Minh City 699
Hong Kong 678
Los Angeles 563
Beijing 544
Moscow 533
Hyderabad 488
Hanoi 468
São Paulo 463
Milan 454
Frankfurt am Main 327
Council Bluffs 290
Dallas 289
Nuremberg 267
New York 266
Washington 266
Santa Clara 248
Rome 233
Chicago 224
Rio de Janeiro 165
Helsinki 132
Paris 124
Baghdad 119
Brooklyn 118
Belo Horizonte 113
Chandler 112
Shanghai 111
Johannesburg 106
Brasília 104
London 104
Munich 104
Seattle 100
St Louis 97
Dhaka 94
Curitiba 93
Buffalo 90
Warsaw 90
Da Nang 87
San Francisco 84
Amman 82
Haiphong 82
Porto Alegre 82
Tashkent 80
Brno 79
Mexico City 77
Campinas 75
Nairobi 73
Lappeenranta 71
Atlanta 70
Boston 68
Montreal 67
Orem 67
Arezzo 64
Pune 64
Amsterdam 59
Guayaquil 59
Vienna 58
Bangkok 55
Chennai 53
Erbil 53
Phoenix 52
Quito 49
Buenos Aires 48
Baku 47
The Dalles 47
Cape Town 46
Guarulhos 46
Houston 46
Jacksonville 46
Ribeirão Preto 46
Salvador 44
Goiânia 43
Guangzhou 43
Istanbul 43
Montevideo 43
Caracas 42
Riyadh 42
Toronto 42
Bologna 41
Lahore 41
Busto Arsizio 38
Mumbai 38
Recife 38
Addis Ababa 37
Fortaleza 37
Asunción 36
Caxias do Sul 36
Denver 35
Jeddah 35
Manchester 35
Biên Hòa 34
Totale 35.273
Salva come PNG Salva come JPEG
Nome #
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism 250
Advancements and challenges in CAR T cell therapy in autoimmune diseases 176
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 156
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells 154
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. Reply 144
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party 140
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study 136
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 135
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 128
Proteomics study of peripheral blood mononuclear cells in down syndrome children 124
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 121
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia 117
KRAS and CREBBP mutations: A relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia 116
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia 114
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial 113
How I treat relapsed childhood acute lymphoblastic leukemia 113
Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 110
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party 109
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 108
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 107
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS 107
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma 105
CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia 101
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 100
Usefulness of 18F-FDG PET/CT in an Unusual Case of Solid-Pseudopapillary Pancreatic Tumor in Childhood With Aggressive Behavior 99
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response 97
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: An I-BFM Study Group collaboration 96
Identification of a new HLA-B*44 allele, HLA-B*44:02:68, by next generation sequencing 95
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome 94
MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs 94
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity 93
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 91
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis 89
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 89
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 89
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches 88
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant 88
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS 88
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 88
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing 87
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD 87
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) 87
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 87
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications 85
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 85
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 85
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease 85
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience 84
Exagamglogene Autotemcel for Severe Sickle Cell Disease 84
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 83
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 83
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 83
Outcome of very late relapse in children with acute lymphoblastic leukemia 82
The role of interferon-gamma and its signaling pathway in pediatric hematological disorders 82
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies 81
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival 80
Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion 79
The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia 79
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients 79
T lymphocytes against solid malignancies: Winning ways to defeat tumours 79
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients 79
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis 79
Systematic identification of edited microRNAs in the human brain 79
Case Report: Trichosporon japonicum Fungemia in a Pediatric Patient With Refractory Acute B Cell Lymphoblastic Leukemia 79
TFG binds LC3C to regulate ULK1 localization and autophagosome formation 79
A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia 78
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference 78
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL 78
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 78
Natural killer cells in the treatment of high-risk acute leukaemia 77
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 77
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations 77
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients 77
Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors 76
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia 76
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia 76
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome 76
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 76
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas 76
Donor natural killer cells trigger production of β-2-microglobulin to enhance post–bone marrow transplant immunity 75
CD28.OX40 co-stimulatory combination is high associated activity with of CAR.CD30 long in vivoT persistence cells and 75
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study 75
Src nuclear localization and its prognostic relevance in human osteosarcoma 75
Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior. 75
Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort 74
Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen 73
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study 73
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children 73
Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features 73
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells 73
B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies 73
Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells 73
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia 72
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies 72
Direct involvement of cranial nerve V at diagnosis in patients with diffuse intrinsic pontine glioma: A potential magnetic resonance predictor of short-term survival 71
Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the Literature 71
Asplenia and spleen hypofunction 71
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines 71
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis 71
Local control in metastatic neuroblastoma in children over 1 year of age 71
Totale 9.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 352.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 352.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 8 16 0
2021/2022142 9 9 5 5 8 6 5 18 7 10 24 36
2022/20231.335 34 47 20 46 27 50 10 38 696 249 68 50
2023/20247.210 213 1.307 420 200 577 1.217 322 292 199 580 691 1.192
2024/202517.551 272 285 1.296 291 668 553 350 433 3.283 1.353 5.048 3.719
2025/202637.358 7.082 1.752 3.715 3.773 6.265 1.808 7.064 1.841 2.332 1.726 0 0
Totale 64.001